{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:12:18Z","timestamp":1760235138386,"version":"build-2065373602"},"reference-count":82,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The future of eye reconstruction invariably includes stem cells transplantation. Corneal limbus, corneal stroma, trabeculum, retinal cells, optic nerve, and all structures that are irreversibly damaged and have no means to be repaired or replaced, through conventional treatment or surgery, represent targets for stem cell reconstruction. This review tries to answer the question if there is any clinical validation for stem therapies, so far, starting from the cornea and, on the path of light, arriving to the retina. The investigation covers the last 10 years of publications. From 2385 published sources, we found 56 clinical studies matching inclusion criteria, 39 involving cornea, and 17 involving retina. So far, corneal epithelial reconstruction seems well validated clinically. Enough clinical data are collected to allow some form of standardization for the stem cell transplant procedures. Cultivated limbal epithelial stem cells (CLET), simple limbal epithelial transplant (SLET), and oral mucosa transplantation are implemented worldwide. In comparison, far less patients are investigated in retinal stem reconstructions, with lower anatomical and clinical success, so far. Intravitreal, subretinal, and suprachoroidal approach for retinal stem therapies face specific challenges.<\/jats:p>","DOI":"10.3390\/biomedicines9080873","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T10:31:44Z","timestamp":1627036304000},"page":"873","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stem Cells in the Path of Light, from Corneal to Retinal Reconstruction"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-0512","authenticated-orcid":false,"given":"Ovidiu","family":"Samoila","sequence":"first","affiliation":[{"name":"Ophthalmology Department, University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d, 400006 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacramioara","family":"Samoila","sequence":"additional","affiliation":[{"name":"Clinica Vedis, 400371 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gonzalez, G., Sasamoto, Y., Ksander, B.R., Frank, M.H., and Frank, N.Y. (2018). Limbal stem cells: Identity, developmental origin, and therapeutic potential. Wiley Interdiscip. Rev. Dev. Biol., 7.","DOI":"10.1002\/wdev.303"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/bjo.2004.049742","article-title":"Limbal epithelial crypts: A novel anatomical structure and a putative limbal stem cell niche","volume":"89","author":"Dua","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.biocel.2003.10.013","article-title":"Stem cells in the eye","volume":"36","author":"Boulton","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10456-016-9497-6","article-title":"Bone marrow-derived cells in ocular neovascularization: Contribution and mechanisms","volume":"19","author":"Gao","year":"2016","journal-title":"Angiogenesis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4252\/wjsc.v7.i5.806","article-title":"Corneal stem cells and tissue engineering: Current advances and future perspectives","volume":"7","author":"Gomes","year":"2015","journal-title":"World J. Stem. Cells"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mazini, L., Rochette, L., Amine, M., and Malka, G. (2019). Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102523"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015013057","article-title":"Adipose-derived stromal vascular fraction cells: Update on clinical utility and efficacy","volume":"25","author":"Han","year":"2015","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/WCO.0b013e3283352f96","article-title":"Induced pluripotent stem cell therapies for retinal disease","volume":"23","author":"Comyn","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"El Zarif, M., Jawad, K.A., Ali\u00f3 Del Barrio, J.L., Jawad, Z.A., Palaz\u00f3n-Bru, A., De Miguel, M.P., Saba, P., Makdissy, N., and Ali\u00f3, J.L. (2020). Corneal stroma cell density evolution in keratoconus corneas following the implantation of adipose mesenchymal stem cells and corneal laminas: An In Vivo confocal microscopy study. Investig. Ophthalmol. Vis. Sci., 61.","DOI":"10.1167\/iovs.61.4.22"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/ICO.0000000000001228","article-title":"Cellular Therapy with Human Autologous Adipose-Derived Adult Stem Cells for Advanced Keratoconus","volume":"36","author":"Azaar","year":"2017","journal-title":"Cornea"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtos.2017.11.002","article-title":"The diagnosis of limbal stem cell deficiency","volume":"16","author":"Le","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0161-6420(89)32833-8","article-title":"Limbal autograft transplantation for ocular surface disorders","volume":"96","author":"Kenyon","year":"1989","journal-title":"Ophthalmology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(96)11188-0","article-title":"Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium","volume":"349","author":"Pellegrini","year":"1997","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1442-9071.2011.02609.x","article-title":"Long-term effectiveness of autologous cultured limbal stem cell grafts in patients with limbal stem cell deficiency due to chemical burns","volume":"40","author":"Marchini","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000315020","article-title":"Midterm Results of Cultivated Autologous and Allogeneic Limbal Epithelial Transplantation in Limbal Stem Cell Deficiency","volume":"Volume 45","author":"Pauklin","year":"2010","journal-title":"Research Projects in Dry Eye Syndrome"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/bjophthalmol-2011-300352","article-title":"Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: A 10-year study","volume":"95","author":"Sangwan","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Basu, S., Ali, H., and Sangwan, V.S. (2012). Clinical outcomes of repeat autologous cultivated limbal epithelial transplantation for ocular surface burns. Am. J. Ophthalmol., 153.","DOI":"10.1016\/j.ajo.2011.09.016"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/bjophthalmol-2011-301164","article-title":"Simple limbal epithelial transplantation (SLET): A novel surgical technique for the treatment of unilateral limbal stem cell deficiency","volume":"96","author":"Sangwan","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/bjophthalmol-2015-307348","article-title":"Autologous simple limbal epithelial transplantation for unilateral limbal stem cell deficiency: Multicentre results","volume":"100","author":"Vazirani","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajo.2016.10.021","article-title":"Concomitant Simple Limbal Epithelial Transplantation After Surgical Excision of Ocular Surface Squamous Neoplasia","volume":"174","author":"Kaliki","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/bjophthalmol-2016-309045","article-title":"Outcome of allo simple limbal epithelial transplantation (alloSLET) in the early stage of ocular chemical injury","volume":"101","author":"Iyer","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ICO.0000000000000242","article-title":"Ocular surface reconstruction by cultivated epithelial sheet transplantation","volume":"33","author":"Satake","year":"2014","journal-title":"Cornea"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10792-016-0415-0","article-title":"Allogenic cultivated limbal stem cell transplantation versus cadaveric keratolimbal allograft in ocular surface disorder: 1-year outcome","volume":"37","author":"Parihar","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2020.00043","article-title":"Clinical Outcomes from Cultivated Allogenic Stem Cells vs. Oral Mucosa Epithelial Transplants in Total Bilateral Stem Cells Deficiency","volume":"7","author":"Samoila","year":"2020","journal-title":"Front. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ophtha.2012.11.001","article-title":"Characteristics of immune rejection after allogeneic cultivated limbal epithelial transplantation","volume":"120","author":"Qi","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_26","first-page":"408495","article-title":"Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures","volume":"2015","author":"Herreras","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00417-016-3410-2","article-title":"Characterization of the corneal surface in limbal stem cell deficiency and after transplantation of cultured allogeneic limbal epithelial cells","volume":"254","author":"Chen","year":"2016","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cheng, J., Zhai, H., Wang, J., Duan, H., and Zhou, Q. (2017). Long-term outcome of allogeneic cultivated limbal epithelial transplantation for symblepharon caused by severe ocular burns. BMC Ophthalmol., 17.","DOI":"10.1186\/s12886-017-0403-9"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/sctm.19-0021","article-title":"Long-Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency","volume":"8","author":"Borderie","year":"2019","journal-title":"Stem. Cells Transl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/sctm.18-0140","article-title":"Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical Trial","volume":"8","author":"Campbell","year":"2019","journal-title":"Stem. Cells Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00417-019-04316-z","article-title":"Comparison of the efficacy of different cell sources for transplantation in total limbal stem cell deficiency","volume":"257","author":"Wang","year":"2019","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/0301-4738.99840","article-title":"Coculture of autologous limbal and conjunctival epithelial cells to treat severe ocular surface disorders: Long-term survival analysis","volume":"61","author":"Subramaniam","year":"2013","journal-title":"Indian J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13287-015-0009-1","article-title":"Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: A prospective case series","volume":"6","author":"Bobba","year":"2015","journal-title":"Stem. Cell Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jtos.2017.11.001","article-title":"The role of amniotic membrane extract eye drop (AMEED) in In Vivo cultivation of limbal stem cells","volume":"16","author":"Asl","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5966\/sctm.2013-0025","article-title":"Three-Year Outcomes of Cultured Limbal Epithelial Allografts in Aniridia and Stevens-Johnson Syndrome Evaluated Using the Clinical Outcome Assessment in Surgical Trials Assessment Tool","volume":"3","author":"Shortt","year":"2014","journal-title":"Stem. Cells Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2217\/rme.13.43","article-title":"Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells","volume":"8","author":"Pellegrini","year":"2013","journal-title":"Regen. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zakaria, N., Possemiers, T., Dhubhghaill, S.N., Leysen, I., Rozema, J., Koppen, C., Timmermans, J.P., Berneman, Z., and Tassignon, M.J. (2014). Results of a phase I\/II clinical trial: Standardized, non-xenogenic, cultivated limbal stem cell transplantation. J. Transl. Med., 12.","DOI":"10.1186\/1479-5876-12-58"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.ophtha.2015.04.004","article-title":"In Vivo Confocal Microscopy 1 Year after Autologous Cultured Limbal Stem Cell Grafts","volume":"122","author":"Pedrotti","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/APO.0000000000000163","article-title":"Optical coherence tomography in cultivated Limbal epithelial stem cell transplantation surgery","volume":"4","author":"Zakaria","year":"2015","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10561-018-09746-3","article-title":"Epithelial analysis of simple limbal epithelial transplantation in limbal stem cell deficiency by in vivo confocal microscopy and impression cytology","volume":"20","author":"Prabhasawat","year":"2019","journal-title":"Cell Tissue Bank."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/ICO.0000000000002153","article-title":"Short- and Long-Term Results of Xenogeneic-Free Cultivated Autologous and Allogeneic Limbal Epithelial Stem Cell Transplantations","volume":"38","author":"Behaegel","year":"2019","journal-title":"Cornea"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jamaophthalmol.2013.2308","article-title":"Cultivated limbal epithelial transplantation in children with ocular surface burns","volume":"131","author":"Sejpal","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2015.12.042","article-title":"Simple Limbal Epithelial Transplantation: Long-Term Clinical Outcomes in 125 Cases of Unilateral Chronic Ocular Surface Burns","volume":"123","author":"Basu","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.11.003","article-title":"A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency","volume":"206","author":"Calonge","year":"2019","journal-title":"Transl. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajo.2019.02.009","article-title":"Regenerative Surgery of the Corneal Stroma for Advanced Keratoconus: 1-Year Outcomes","volume":"203","author":"Azaar","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa040455","article-title":"Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium","volume":"351","author":"Nishida","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bjo.2010.188714","article-title":"Long-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders","volume":"95","author":"Nakamura","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ophtha.2011.01.039","article-title":"Long-term Outcome of Cultivated Oral Mucosal Epithelial Sheet Transplantation in Treatment of Total Limbal Stem Cell Deficiency","volume":"118","author":"Satake","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2012.07.053","article-title":"Visual Improvement after Cultivated Oral Mucosal Epithelial Transplantation","volume":"120","author":"Sotozono","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1167\/iovs.11-7744","article-title":"Cultured Autologous Oral Mucosal Epithelial Cell Sheet (CAOMECS) Transplantation for the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency","volume":"53","author":"Burillon","year":"2012","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_51","first-page":"181","article-title":"Long-Term Results of Cultured Autologous Oral Mucosa Epithelial Cell-Sheet (CAOMECS) Graft for the Treatment of Blindness Due to Bilateral Limbal Stem Cell Deficiency","volume":"4","author":"Kocaba","year":"2014","journal-title":"J. Stem. Cell Res. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Dobrowolski, D., Orzechowska-Wylegala, B., Wowra, B., Wroblewska-Czajka, E., Grolik, M., Szczubialka, K., Nowakowska, M., Puzzolo, D., Wylegala, E.A., and Micali, A. (2015). Cultivated Oral Mucosa Epithelium in Ocular Surface Reconstruction in Aniridia Patients. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/281870"},{"key":"ref_53","unstructured":"Kim, Y., Hyun, J.L., Jin, S.R., Kim, Y.H., Jeon, S., Choung, H.K., Khwarg, S.I., Wee, W.R., Kim, M.K., and Epithelial, M. (2017). Prospective Clinical Trial of Corneal Reconstruction With Sheets. Cornea, 1\u20138."},{"key":"ref_54","unstructured":"(2021, February 09). The Eye and Stem Cells: The Path to Treating Blindness|Eurostemcell. Available online: https:\/\/www.eurostemcell.org\/eye-and-stem-cells-path-treating-blindness."},{"key":"ref_55","unstructured":"(2017). Pioneering cell transplant shows vision and promise. Nature, 544, 5."},{"key":"ref_56","first-page":"133","article-title":"Evaluation of Patients with Retinitis Pigmentosa Receiving Electric Stimulation, Ozonated Blood, and Ocular Surgery in Cuba","volume":"115","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/archopht.1996.01100130552009","article-title":"Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood, and ocular surgery in Cuba","volume":"114","author":"Berson","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/MD.0000000000000355","article-title":"Preliminary study on electrophysiological changes after cellular autograft in age-related macular degeneration","volume":"93","author":"Limoli","year":"2014","journal-title":"Medicine"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Limoli, P.G., Vingolo, E.M., Limoli, C., Scalinci, S.Z., and Nebbioso, M. (2018). Regenerative therapy by suprachoroidal cell autograft in dry age-related macular degeneration: Preliminary in vivo report. J. Vis. Exp., 2018.","DOI":"10.3791\/56469"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/IAE.0b013e3181f9c242","article-title":"Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: A phase i trial","volume":"31","author":"Siqueira","year":"2011","journal-title":"Retina"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Siqueira, R.C., Messias, A., Messias, K., Siqueira, R.C., Messias, A., Messias, K., Arcieri, R.S., Ruiz, M.A., Souza, N.F., and Martins, L.C. (2015). Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell-clinical trial). Stem. Cell Res. Ther., 6.","DOI":"10.1186\/s13287-015-0020-6"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1167\/iovs.14-15415","article-title":"Intravitreal autologous bone marrow cd34+ cell therapy for ischemic and degenerative retinal disorders: Preliminary phase 1 clinical trial findings","volume":"56","author":"Park","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0432-y","article-title":"Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: A phase I clinical safety study","volume":"7","author":"Oner","year":"2016","journal-title":"Stem. Cell Res. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/cell.2018.0045","article-title":"Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and stargardt\u2019s macular dystrophy: 6-month follow-up results of a phase 2 study","volume":"20","author":"Oner","year":"2018","journal-title":"Cell Reprogram"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Liu, Y., Chen, S.J., Li, S.Y., Li, Y., Qu, L.H., Meng, X.M., Wang, Y., Xu, H.W., Liang, Z.Q., and Yin, Z.Q. (2017). Long-Term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients. Stem. Cell Res. Ther., 8.","DOI":"10.1186\/s13287-017-0661-8"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.ophtha.2018.04.037","article-title":"Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration","volume":"125","author":"Mehat","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_68","unstructured":"(2021, January 01). Stem Cell Ophthalmology Treatment Study-Full Text View-ClinicalTrials.Gov, Available online: https:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT01920867?term=scots&draw=2&rank=5."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Weiss, J.N., Levy, S., and Benes, S.C. (2017). Stem Cell Ophthalmology Treatment Study: Bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION). Stem. Cell Investig., 4.","DOI":"10.21037\/sci.2017.11.05"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Weiss, J.N., and Levy, S. (2018). Stem Cell Ophthalmology Treatment Study: Bone marrow derived stem cells in the treatment of Retinitis Pigmentosa. Stem. Cell Investig., 5.","DOI":"10.21037\/sci.2018.04.02"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4103\/1673-5374.193251","article-title":"Stem cell ophthalmology treatment study (SCOTS): Bone marrow-derived stem cells in the treatment of Leber\u2019s hereditary optic neuropathy","volume":"11","author":"Weiss","year":"2016","journal-title":"Neural Regen. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4103\/1673-5374.158365","article-title":"Stem cell ophthalmology treatment study (SCOTS) for retinal and optic nerve diseases: A preliminary report","volume":"10","author":"Weiss","year":"2015","journal-title":"Neural. Regen. Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Weiss, J.N., and Levy, S. (2020). Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Age-Related Macular Degeneration. Medicines, 7.","DOI":"10.3390\/medicines7040016"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Weiss, J.N., and Levy, S. (2019). Stem cell Ophthalmology Treatment Study (SCOTS): Bone marrow derived stem cells in the treatment of Usher syndrome. Stem. Cell Investig., 6.","DOI":"10.21037\/sci.2019.08.07"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/sci.2019.11.01","article-title":"Stem Cell Ophthalmology Treatment Study (SCOTS): Bone marrow derived stem cells in the treatment of Dominant Optic Atrophy","volume":"6","author":"Weiss","year":"2019","journal-title":"Stem. Cell Investig."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kashani, A.H., Lebkowski, J.S., Rahhal, F.M., Avery, R.L., Salehi-Had, H., Dang, W., Lin, C.M., Mitra, D., Zhu, D., and Thomas, B.B. (2018). A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Sci. Transl. Med., 10.","DOI":"10.1126\/scitranslmed.aao4097"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3109\/02713683.2015.1095932","article-title":"Recreating the Human Limbal Epithelial Stem Cell Niche with Bioengineered Limbal Crypts","volume":"41","author":"Levis","year":"2016","journal-title":"Curr. Eye Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e016487","DOI":"10.1136\/bmjopen-2017-016487","article-title":"A study protocol for a multicentre randomised clinical trial evaluating the safety and feasibility of a bioengineered human allogeneic nanostructured anterior cornea in patients with advanced corneal trophic ulcers refractory to conventional treatment","volume":"7","author":"Mata","year":"2017","journal-title":"BMJ Open."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1167\/iovs.14-14800","article-title":"Induction of trabecular meshwork cells from induced pluripotent stem cells","volume":"55","author":"Ding","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Geng, Z., Walsh, P.J., Truong, V., Hill, C., Ebeling, M., Kapphahn, R.J., Montezuma, S.R., Yuan, C., Roehrich, H., and Ferrington, D.A. (2017). Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173575"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Cyranoski, D. (2019). Woman is first to receive cornea made from \u2018reprogrammed\u2019 stem cells. Nature.","DOI":"10.1038\/d41586-019-02597-2"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actbio.2017.11.058","article-title":"Fibrin hydrogels as a xenofree and rapidly degradable support for transplantation of retinal pigment epithelium monolayers","volume":"67","author":"Gandhi","year":"2018","journal-title":"Acta Biomater."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/873\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:33:58Z","timestamp":1760164438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":82,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["biomedicines9080873"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9080873","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2021,7,23]]}}}